Cite
Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study.
MLA
Kirkegaard-Klitbo, Ditte Marie, et al. “Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-Morbidity Liver Study.” Journal of Infectious Diseases, vol. 222, no. 8, Oct. 2020, pp. 1353–62. EBSCOhost, https://doi.org/10.1093/infdis/jiaa246.
APA
Kirkegaard-Klitbo, D. M., Fuchs, A., Stender, S., Sigvardsen, P. E., Kühl, J. T., Kofoed, K. F., Køber, L., Nordestgaard, B. G., Bendtsen, F., Mocroft, A., Lundgren, J., Nielsen, S. D., & Benfield, T. (2020). Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study. Journal of Infectious Diseases, 222(8), 1353–1362. https://doi.org/10.1093/infdis/jiaa246
Chicago
Kirkegaard-Klitbo, Ditte Marie, Andreas Fuchs, Stefan Stender, Per Ejlstrup Sigvardsen, Jørgen Tobias Kühl, Klaus Fuglsang Kofoed, Lars Køber, et al. 2020. “Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-Morbidity Liver Study.” Journal of Infectious Diseases 222 (8): 1353–62. doi:10.1093/infdis/jiaa246.